Rapid Proteomic Profiling by MALDI-TOF Mass Spectrometry for Better Brain Tumor Classification.
Graciane PetreHarmonie DurandLaurent PelletierMargot PoulenardGuillaume NuguePierre F RayJohn RenduCharles CouttonFrancois BergerMarie BidartPublished in: Proteomics. Clinical applications (2020)
In the study, the authors showed the ability of MALDI-TOF profiling to discriminate glioblastoma cell lines, demonstrating that this technique could be used in complement to histological tumor classification. The proposed procedure is rapid and inexpensive and could be used to improve brain tumors classification and help propose a personalized and more efficient treatment.